본문 바로가기
bar_progress

Text Size

Close

Celltrion Moves to Acquire US Plant... Turning Point for Pharmaceutical and Biotech Industry [3-Minute Brief]

① Celltrion Moves to Acquire US Plant
② Value-Up Lifts, Tax Reform Dampens... Ruling Party Hints at Reassessment
③ POSCO Considers Withdrawing New Automotive Steel Investment

MARKET INDEX
Celltrion Moves to Acquire US Plant... Turning Point for Pharmaceutical and Biotech Industry [3-Minute Brief]

○All three major New York stock indices rose simultaneously.
○"Trump announces Apple’s $100 billion investment"
○Despite mixed corporate earnings, Apple surged 5%, leading the market higher.

TOP 3 NEWS
■ "Drugs once made in Korea, now in the US"... Celltrion's acquisition of a US plant marks a turning point for the pharmaceutical and biotech industry
○Celltrion is moving to acquire a cGMP manufacturing facility.
○Samsung Biologics and others are also considering investments in the US.
○Due to tariffs initiated by Trump, the export formula for Korean manufacturing and local demand has changed.
■ Stock prices lifted by value-up, dropped by tax reform... Is a reassessment possible?
○100 trillion won in market capitalization evaporated after the government proposal announcement
○Major shareholder capital gains tax threshold strengthened to 1 billion won
○In response to market shock, the ruling party hints at a complete reassessment
■ Aftermath of tariff barriers... POSCO considers withdrawing expansion of automotive steel facilities
○Reconsideration of new investment in Gwangyang CGL
○Core export products and related industries are hit
○Chinese low-price competition also hampers facility expansion
Graphic News: Removing Obstacles to Venture Investment Will Help BDCs Grow [What Is a Venture Investment BDC?]
Celltrion Moves to Acquire US Plant... Turning Point for Pharmaceutical and Biotech Industry [3-Minute Brief]

○Allowing BDCs to borrow funds... Parallel regulations ease concerns over 'investor losses'
○Introduction of fund-of-funds type BDCs... Easier capital raising and risk diversification
○Activating the venture investment ecosystem will amplify the effects of BDC introduction

Money-Making Law
Celltrion Moves to Acquire US Plant... Turning Point for Pharmaceutical and Biotech Industry [3-Minute Brief]
■ "Stronger Commercial Act, Side Effects Need Review"?Opinion from the Court Administration Office
○Regarding the ruling party's 'stronger Commercial Act', courts and the Ministry of Justice take a cautious stance, weighing effectiveness and side effects
○Concerns raised over the introduction of cumulative voting, citing potential infringement on private autonomy and voting rights
○Expansion of separate election of audit committee members requires review of corporate burden and social changes
☞Read the article: https://www.asiae.co.kr/article/lawtimes/2025080707021644918 
■ Adultery caught on concert screen... Can the organizer be sued for damages?
○Adultery scene captured on concert screen... CEO resigns, divorce lawsuit follows
○If the incident leads to a divorce lawsuit in Korea, the amount of compensation is likely to increase
○Difficult to win damages against Coldplay, as the act falls within the scope of production
☞Read the article:  https://www.asiae.co.kr/article/lawtimes/2025080707054463627
■ 'SK Hynix China Plant Fire'?Sungdo ENG... Supreme Court: "Delayed damages must be reconsidered"
○Supreme Court: "Sungdo ENG jointly liable for fire compensation... but the decision on delayed damages was incorrect"
○After the subsidiary's accident, a large dividend was paid... Under Chinese law, some responsibility of the parent company is recognized
○Delayed damages must also be reviewed according to Chinese law... Case remanded to Seoul High Court
☞Read the article:  https://www.asiae.co.kr/article/lawtimes/2025080707074874303

※ 'Money-Making Law', a content partnership section between Asia Economy and Law Times, is published every Tuesday and Thursday.

Today's Key Schedule

○Domestic

KOSDAQ: IT Chem listed, confirmed offering price 16,100 won

KOSDAQ: SNCYS subscription, confirmed offering price 30,000 won

KOSDAQ: S2W subscription, expected offering price 11,400~13,200 won

06:00 Foreign exchange reserves (USD) (July)

08:00 Current account balance (June)


○Overseas

12:00 China imports (YoY) (July)

12:00 China trade balance (USD) (July)

15:00 Germany industrial production (MoM) (June)

17:00 European Central Bank monthly report

21:30 US initial jobless claims

23:00 US FOMC member Bostic speech

◇Lunch & Evening Weather
○Lowest temperature: 25°C (2°C) |Highest temperature: 32°C (3°C)
○Precipitation probability: 10% in the morning|10% in the afternoon
○Fine dust: Good in the morning|Good in the afternoon
Celltrion Moves to Acquire US Plant... Turning Point for Pharmaceutical and Biotech Industry [3-Minute Brief]

Just 3 minutes for essential, high value-for-time economic news. Published daily at 8:00 AM.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top